Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome

Human Reproduction

Volumn 29, Issue 7, 2014, Pages 1508-1517

  Ezeh, Uche ^a,b   Pall, Marita ^a   Mathur, Ruchi ^a   Azziz, Ricardo ^a,b,c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

androgens; fat body mass; insulin resistance; lean body mass; PCOS

Indexed keywords

GLUCOSE; INSULIN; PRASTERONE SULFATE; TESTOSTERONE;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSIS RELATED GROUP; DIET RESTRICTION; DISEASE MARKER; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOCRINE FUNCTION TEST; FEMALE; GLUCOSE TRANSPORT; HOMEOSTASIS; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERANDROGENISM; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; METABOLIC DISORDER; METABOLIC PARAMETERS; METHODOLOGY; OVARY POLYCYSTIC DISEASE; PROSPECTIVE STUDY; TERTIARY HEALTH CARE; WAIST HIP RATIO; ADIPOSE TISSUE; CASE CONTROL STUDY; COMPLICATION; GLUCOSE TOLERANCE TEST; IMPEDANCE; METABOLIC SYNDROME X; METABOLISM; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; YOUNG ADULT;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADULT; BODY COMPOSITION; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ELECTRIC IMPEDANCE; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; HYPERANDROGENISM; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84902651572     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu096     Document Type: Article

References (53)

1. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A, for the AlkaMeSy Study Group. Visceral Adiposity Index; A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 2010;33:920-922.
2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004a;89:2745-2749.
3. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KS, Taylor K, Boots LR. Androgen excess in women: Experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004b;89:453-462.
4. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE et al. ; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91:456-488.
5. Bergman RN. Lilly lecture. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 1989;38:1512-1517.
6. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, Casaburi R. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996;335:1-7.
7. Bhattacharya SM, Jha A. Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome. Fertil Steril 2012;98:1053-1059.
8. Carmina E, Guastella E, Longo RA, Rini GB, Lobo RA. Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Eur J Endocrinol 2009;1:583-589.
9. Chazenbalk G, Trivax BS, Yildiz BO, Bertolotto C, Mathur R, Heneidi S, Azziz R. Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-alpha. J Clin Endocrinol Metab 2010;95:935-942.
10. Chazenbalk G, Chen YH, Heneidi S, Lee JM, Pall M, Chen YD, Azziz R. Abnormal expression of genes involved in inflammation, lipid metabolism, andWnt signaling in the adipose tissue of polycystic ovary syndrome. J Clin Endocrinol Metab 2012;97:E765-E770.
11. Chen YH, Heneidi S, Lee JM, Layman LC, Stepp DW, Gamboa GM, Chen BS, Chazenbalk G, Azziz R. miRNA-93 inhibitsGLUT4and is overexpressed in adipose tissue of Polycystic Ovary Syndrome patients and women with insulin resistance. Diabetes 2013;62:2278-2286.
12. Chow S, Shao J, Wang H. Sample Size Calculations in Clinical Research, 2nd edn. Chapman and Hall/CRC, Newyork, 2008, 243-244.
13. Comerford KB, Almario RU, Kim K, Karakas SE. Lean mass and insulin resistance in women with polycystic ovary syndrome. Metabolism 2012; 61:1256-1260.
14. Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2006;91:492-497.
15. DeFronzo RA, Gunnarsson R, Bjorkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin dependent (type II) diabetes mellitus. J Clin Invest 1985;76:149-155.
16. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P. Abdominal obesity and the metabolic syndrome contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008;28:1039-1049.
17. DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005;83:1454-1460.
18. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes:: A systematic review and meta-analysis. JAMA 2006;295:1288-1299.
19. Douchi T, Yamamoto S, Oki T, Maruta K, Kuwahata R, Nagata Y. Serum androgen levels and muscle mass in women with polycystic ovary syndrome. Obstet Gynecol 1999;94:337-340.
20. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800.
21. Ezeh U, Pall M, Mathur R, Dey D, Berman D, Chen IY, Dumesic DA, Azziz R et al. Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulinmediated glucose uptake in females. J Clin Endocrinol Metab 2013a; 98:1541-1548.
22. Ezeh U, Yildiz BO, Azziz R. Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metab 2013b;98:E1088-E1096.
23. Farah-Eways L, Reyna R, Knochenhauer ES, Bartolucci AA, Azziz R. Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome. Fertil Steril 2004;281:120-125.
24. Florez H, Castillo-Florez S. Beyond the obesity paradox in diabetes: fitness, fatness, and mortality. JAMA 2012;308:619-620.
25. Forbes GB, Welle SL. Lean body mass in obesity. Int J Obes (London) 1983; 7:99-107.
26. He J, Watkins S, Kelley DE. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 2001;50:817-823.
27. Heshka S, Ruggiero A, Bray GA, Foreyt J, Kahn SE, Lewis CE, Saad M, Schwartz AV. Altered body composition in type 2 diabetes mellitus. Int J Obes (Lond) 2008;32:780-787.
28. Kirchengaast S, Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod 2001;16:1255-1260.
29. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-3082.
30. Kuk JL, Kilpatrick K, Davidson LE, Hudson R, Ross R. Whole-body skeletal muscle mass is not related to glucose tolerance or insulin sensitivity in overweight and obese men and women. Appl Physiol Nutr Metab 2008; 33:769-774.
31. Lavie CJ, De Schutter A, Patel D, Artham SM, Milani RV. Body composition and coronary heart disease mortality-an obesity or a lean paradox? Mayo Clin Proc 2011;86:857-864.
32. Lavie CJ, De Schutter A, Patel DA, Romero-Corral A, Artham SM, Milani RV. Body composition and survival in stable coronary heart disease. Impact of lean mass index and body fat in the obesity paradox. J Am Coll Cardiol 2012;60:1374-1380.
33. Lear SA, Kohli S, Bondy GP, Tchernof A, Sniderman AD. Ethnic variation in fat and lean body mass and the association with insulin resistance. J Clin Endocrinol Metab 2009;94:4696-4702.
34. Lee SY, Gallagher D. Assessment methods in human body composition. Curr Opin Clin Nutr Metab Care 2008;11:566-572.
35. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
36. Miller JP, Pratley RE, Goldberg AP, Gordon P, Rubin M, Treuth MS, Ryan AS, Hurley BF. Strength training increases insulin action in healthy 50-to 65-yr-old men. J Appl Physiol 1994;77:1122-1127.
37. Nam SY, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Int J Obes Relat Metab Disord 2001; 25:1101-1107.
38. Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, Grundy SM, Khera A, McGuire DK, de Lemos JA. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012; 308:1150-1159.
39. NIH. Bioelectrical impedance analysis in body composition measurement: Proceedings of a National Institutes of Health Technology Assessment Conference. Am J Clin Nutr 1996;64(Suppl. 3):S524-S532.
40. Oh JY, Sung YA, Lee HJ. The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome. Obesity (Silver Spring) 2013;21:1690-1694.
41. Preis SR, Massaro JM, Robins SJ, Hoffmann U, Vasan RS, Irlbeck T, Meigs JB, Sutherland P, DAgostino RB Sr, ODonnell CJ et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring) 2010;18:2191-2198.
42. Rariy CM, Ratcliffe SJ, Weinstein R, Bhasin S, Blackman MR, Cauley JA, Robbins J, Zmuda JM, Harris TB, Cappola AR. Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the cardiovascular health study. J Clin Endocrinol Metab 2011;96:989-996.
43. Romero-Corral A, Lopez-Jimenez F, Sierra-Johnson J, Somers VK. Differentiating between body fat and lean mass-how should we measure obesity? Nat Clin Pract Endocrinol Metab 2008;4:322-323.
44. Schutz Y, Kyle UU, Pichard C. Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98 y. Int J Obes Relat Metab Disord 2002;26:953-960.
45. Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and pre-diabetes. Findings from the Third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 2011;96:2898-2903.
46. Stanfield KM, Wells JC, Fewtrell MS, Frost C, Leon DA. Differences in body composition between infants of South Asian and European ancestry: the London Mother and Baby Study. Int J Epidemiol 2012; 41:1409-1418.
47. Svendsen PF, Nilas L, Nrgaard K, Jensen JE, Madsbad S. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Hum Reprod 2008;23:2113-2121.
48. Van Der Heijden GJ, Wang ZJ, Chu Z, Toffolo G, Manesso E, Sauer PJ, Sunehag AL. Strength exercise improves muscle mass and hepatic insulin sensitivity in obese youth. Med Sci Sports Exerc 2010;42: 1973-1980.
49. Wang JG, Zhang Y, Chen HE, Li Y, Cheng XG, Xu L, Guo Z, Zhao XS, Sato T, CaoQYet al. Comparison of two bioelectrical impedance analysis devices with dual energy X-ray absorptiometry and magnetic resonance imaging in the estimation of body composition. J Strength Cond Res 2013; 27:236-243.
50. Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am J Clin Nutr 2007;86:1339-1346.
51. Wehr E, Gruber HJ, Giuliani A, Mö ller R, Pieber TR, Obermayer-Pietsch B. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. J Clin Endocrinol Metab 2011;96:E986-E990.
52. Woods KS, Reyna R, Azziz R. Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndrome. Fertil Steril 2002;77:1125-1127.
53. Zawadzki J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens J, Haseltine F, Marrian G (eds). Polycystic Ovary Syndrome. Current Issues in Endocrinology and Metabolism. Boston: Blackwell Scientific, 1992, 4:377-384.